Listed Price₹750.00
Listing Gain+4.17%
Price Band₹695 - ₹720
Lot Size20 shares
Min Bid₹14,400
SubscriptionTracking
Listed Market Snapshot
₹750.00Listed price from market data
+4.17%listing gain
Issue Amount
₹1,514 Cr
Listed Price
₹750.00
Current Price
₹1070.3
Registrar
Kfin Technologies Limited
Timeline•Bookbuilding IPO
Open27 Jul 2021
Close29 Jul 2021
Allotment03 Aug 2021
Listing06 Aug 2021
Quota Reservation Portions
QIBPortion: 1,05,11,110 shares
50%AnchorPortion: 63,06,660 shares
30%Nii (hni)Portion: 31,53,334 shares
15%RetailPortion: 73,57,778 shares
35%Minimum Application Bracket Matrix
Retail1 lots / 20 shares
₹14,400sHNI13 lots / 280 shares
₹2,01,600bHNI70 lots / 1,400 shares
₹10,08,000About the Company
Incorporated in 2011, Glenmark Life Sciences is a leading manufacturer of active pharmaceutical ingredients (APIs), developing and supplying high-quality products used in treatments for cardiovascular, central nervous system, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. The company serves customers in India and exports its products to several international markets including Europe, North America, Latin America, and Japan. It operates four manufacturing facilities located at Ankleshwar and Dahej in Gujarat, and Mohol and Kurkumbh in Maharashtra, with a total annual installed capacity of 725.8 KL as of December 31, 2020.
Company Promoters
Glenmark Pharmaceuticals Limited
Lead Managers
Registrar
Kfin Technologies Limited